Physician

Adam Kaufman, M.D.

According to 2025 Medicare claims, Adam Kaufman, M.D. (NPI: 1831417021) practices psychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Rockland, NY. Kaufman uses personal NPI as billing NPI.

Kaufman's data goes back to 2015 and runs through 2024. For example, in 2022, this provider had 76 traditional Medicare patients, billed 339 HCPCS/CPT codes, and received $22,018 in Medicare payments. 2024 Part D data shows 210 prescription claims across 15 beneficiaries totaling $46,063 in drug costs, led by Rexulti (Brexpiprazole). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $122,472 and ending at $46,063. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	18	128	$7,295
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	127	567	$17,379
2019	137	647	$23,902
2020	96	496	$23,511
2021	86	598	$42,180
2022	76	339	$22,018
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	901	$122,472
2016	15	178	$28,848
2017	16	201	$30,712
2018	206	3,542	$284,578
2019	212	4,301	$447,300
2020	167	2,690	$249,434
2021	109	2,074	$259,300
2022	98	1,525	$229,033
2023	21	193	$49,001
2024	15	210	$46,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rexulti	Brexpiprazole	22	780	$37,507
Citalopram Hbr	Citalopram Hydrobromide	12	680	$1,743
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	370	$306
Quetiapine Fumarate	Quetiapine Fumarate	18	1,140	$265
Lorazepam	Lorazepam	14	405	$140

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adam Kaufman, M.D.?

Tedicare shows public-source Medicare data for Adam Kaufman, M.D. (NPI 1831417021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Kaufman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Kaufman, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Adam Kaufman, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.